Redmile Group, LLC - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 91 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 6.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$174,000
-17.9%
38,9120.0%0.00%0.0%
Q2 2021$212,000
-86.6%
38,912
-81.7%
0.00%
-86.4%
Q1 2021$1,588,000
-31.0%
212,2910.0%0.02%
-21.4%
Q4 2020$2,303,000
+22.7%
212,2910.0%0.03%
-17.6%
Q3 2020$1,877,000
-17.1%
212,2910.0%0.03%
-19.0%
Q2 2020$2,263,000
+79.7%
212,2910.0%0.04%
+20.0%
Q1 2020$1,259,000
-14.2%
212,2910.0%0.04%0.0%
Q4 2019$1,467,000
-96.4%
212,291
-94.5%
0.04%
-97.4%
Q3 2019$40,365,000
+20.4%
3,888,752
+7.4%
1.35%
+42.4%
Q2 2019$33,525,000
+123.0%
3,620,376
+120.1%
0.95%
+115.7%
Q1 2019$15,037,000
+63.7%
1,645,200
-0.3%
0.44%
+18.9%
Q4 2018$9,188,000
-53.4%
1,649,538
-0.4%
0.37%
-39.0%
Q3 2018$19,725,000
+18.4%
1,656,138
+1.5%
0.61%
+7.2%
Q2 2018$16,655,000
-22.3%
1,631,237
-1.3%
0.57%
-31.6%
Q1 2018$21,446,000
+245.9%
1,652,240
+159.3%
0.83%
+206.7%
Q4 2017$6,200,000
-34.3%
637,232
-0.7%
0.27%
-42.1%
Q3 2017$9,442,000
-39.7%
641,419
-34.1%
0.47%
-51.1%
Q2 2017$15,660,000
+3.2%
973,260
+2.2%
0.95%
-3.2%
Q1 2017$15,177,000
+31.6%
952,740
+0.5%
0.98%
-0.9%
Q4 2016$11,533,000
-1.7%
948,440
+6.2%
0.99%
+6.5%
Q3 2016$11,736,000
-22.1%
892,782
-5.6%
0.93%
-35.1%
Q2 2016$15,058,000946,1821.44%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 4,806,656$58,449,00019.02%
Casdin Capital, LLC 182,141$2,215,0001.83%
Aisling Capital LLC 508,565$6,184,0001.44%
Redmile Group, LLC 948,440$11,533,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,812,778$22,043,0000.91%
EcoR1 Capital, LLC 63,596$773,0000.25%
Eventide Asset Management 150,000$1,824,0000.12%
AWM Investment Company, Inc. 47,550$578,0000.11%
Weiss Multi-Strategy Advisers LLC 49,000$596,0000.03%
Baker Brothers Advisors 204,465$2,486,0000.02%
View complete list of SYROS PHARMACEUTICALS INC shareholders